\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ follow\\ up\\ on\\ complicated\\ cysts\\ is\\ best\\ performed\\ at\\ 6\\ weeks\\ following\\ the\\ original\\ finding\\ to\\ ensure\\ the\\ patient\\ is\\ at\\ a\\ different\\ phase\\ of\\ the\\ menstrual\\ cycle\\.\ \(0\)\
\-\ often\\ bcps\\ can\\ be\\ perscribed\\ in\\ order\\ to\\ regulate\\ the\\ ovulation\\ cycle\\ and\\ decrease\\ the\\ likelihood\\ of\\ functional\\ or\\ hemorrhagic\\ cysts\\ on\\ followup\ \(0\)\
\-\ complex\\ cystic\\ mass\\ with\\ low\\ level\\ internal\\ echoes\\.\ \(0\)\
\-\ 7\\.8\\ cm\\ in\\ greatest\\ diameter\ \(1\)\
\-\ \\‚\\Ä\\úfishnet\\ weave\\‚\\Ä\\ù\\ pattern\\ of\\ internal\\ echoes\\.\ \(0\)\
\-\ fine\\ interdigitating\\ septations\\.\ \(0\)\
\-\ no\\ color\\ doppler\\ signal\ \(0\)\
\-\ hemmorrhagic\\ cyst\ \(0\)\
\-\ ddx\\ for\\ a\\ complex\\ or\\ large\\ adnexal\\ lesion\\:\ \(0\)\
\-\ 1\\.\\ \\ hemmorrhagic\\ ovarian\\ cyst\ \(0\)\
\-\ 2\\.\\ \\ endometrioma\ \(0\)\
\-\ 3\\.\\ \\ ectopic\\ pregnancy\\ \\(\\ \\+hcg\\,\\ no\\ intrauterine\\ pregnancy\\)\ \(0\)\
\-\ 4\\.\\ \\ ovarian\\ tumors\ \(0\)\
\-\ \\ \\ \\ \\ \\ epithelial\\ tumors\\ \\-\\ cystadenoma\\,\\ cystadenocarcinoma\ \(1\)\
\-\ \\ \\ \\ \\ \\ germ\\ cell\\ tumor\\ \\-\\ teratomas\\ or\\ \\"dermoids\\"\ \(1\)\
\-\ 5\\.\\ \\ abscess\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ tubo\\ ovarian\\ abscess\\ secondary\\ to\\ pid\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ appendicitis\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ divertticulitis\ \(0\)\
\-\ 6\\.\\ \\ hydrosalpinx\\/pyosalpinx\\ \\(pid\\)\ \(0\)\
\-\ g4\\,\\ p313\\ with\\ documented\\ right\\ ovarian\\ cyst\\ from\\ outside\\ hospital\\ measuring\\ 6\\ x\\ 5\\ cm\\ admitted\\ with\\ persistent\\ worsening\\ pain\\.\ \(0\)\
\-\ hemorrhagic\\ cysts\\ are\\ included\\ in\\ the\\ differential\\ diagnosis\\ for\\ a\\ complex\\ cyst\\ which\\ includes\\:\\ functioning\\ and\\ nonfunctioning\\ hemorrhagic\\ cyst\\,\\ endometrioma\\,\\ dermoid\\,\\ torsion\\,\\ abscess\\,\\ pyo\\/hydrosalpix\\,\\ and\\ cystic\\ neoplasms\\ \\(both\\ benign\\ and\\ malignant\\)\\.\ \(0\)\
\-\ all\\ cystic\\ lesions\\ should\\ be\\ evaluted\\ for\\ malignant\\ features\\ such\\ as\\ wall\\ thickness\\,\\ inner\\ wall\\ structure\\,\\ septa\\ and\\ echogenicity\\.\\ \\ \ \(0\)\
\-\ hemorrhagic\\ cysts\\ are\\ variable\\ in\\ presentation\\ but\\ findings\\ which\\ favor\\ this\\ diagnosis\\ is\\ absence\\ of\\ internal\\ flow\\,\\ good\\ through\\ transmission\\,\\ and\\ reticular\\ fishnet\\ weave\\ pattern\\.\\ \\ if\\ sonographic\\ findings\\ are\\ not\\ strongly\\ favorable\\ for\\ malignancy\\,\\ follow\\-up\\ in\\ 1\\-2\\ menstrual\\ cycles\\ is\\ indicated\\ as\\ most\\ hemorrhagic\\ cysts\\ resolve\\ in\\ this\\ time\\ period\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.26872832820739156\ \(0\)\
\-\ cysts\\:\\ 0\\.2347565565722647\ \(0\)\
\-\ ovarian\\:\\ 0\\.21114659304867078\ \(0\)\
\-\ weave\\:\\ 0\\.1981741204591252\ \(0\)\
\-\ hemmorrhagic\\:\\ 0\\.1981741204591252\ \(0\)\
\-\ fishnet\\:\\ 0\\.18936595184908048\ \(0\)\
\-\ cyst\\:\\ 0\\.17871135162257248\ \(0\)\
\-\ pid\\:\\ 0\\.15751180735473896\ \(0\)\
\-\ echoes\\:\\ 0\\.14419296076408372\ \(0\)\
\-\ menstrual\\:\\ 0\\.14330615940055724\ \(0\)\
\-\ complex\\:\\ 0\\.14321723895505595\ \(0\)\
\-\ cycle\\:\\ 0\\.14245414365974005\ \(0\)\
\-\ endometrioma\\:\\ 0\\.13478958733970317\ \(0\)\
\-\ internal\\:\\ 0\\.12527157073716114\ \(0\)\
\-\ abscess\\:\\ 0\\.11935826578468452\ \(0\)\
\-\ cystic\\:\\ 0\\.11194867111099237\ \(0\)\
\-\ pregnancy\\:\\ 0\\.1014095869677963\ \(0\)\
\-\ bcps\\:\\ 0\\.0990870602295626\ \(0\)\
\-\ perscribed\\:\\ 0\\.0990870602295626\ \(0\)\
\-\ divertticulitis\\:\\ 0\\.0990870602295626\ \(0\)\
\-\ g4\\:\\ 0\\.0990870602295626\ \(0\)\
\-\ p313\\:\\ 0\\.0990870602295626\ \(0\)\
\-\ evaluted\\:\\ 0\\.0990870602295626\ \(0\)\
\-\ regulate\\:\\ 0\\.09468297592454024\ \(0\)\
\-\ interdigitating\\:\\ 0\\.09468297592454024\ \(0\)\
\-\ pattern\\:\\ 0\\.09251738105085985\ \(0\)\
\-\ in\\:\\ 0\\.09248138558948309\ \(0\)\
\-\ tumors\\:\\ 0\\.09113634982128466\ \(0\)\
\-\ ovulation\\:\\ 0\\.08913448588867035\ \(0\)\
\-\ malignant\\:\\ 0\\.08833417443975393\ \(0\)\
\-\ nonfunctioning\\:\\ 0\\.08402939653456369\ \(0\)\
\-\ dermoids\\:\\ 0\\.08275005977201841\ \(0\)\
\-\ tubo\\:\\ 0\\.07962531222954132\ \(0\)\
\-\ cycles\\:\\ 0\\.07720156973614851\ \(0\)\
\-\ and\\:\\ 0\\.07681928934338189\ \(0\)\
\-\ wall\\:\\ 0\\.0753816118791316\ \(0\)\
\-\ for\\:\\ 0\\.07511804673549904\ \(0\)\
\-\ teratomas\\:\\ 0\\.07463396012797881\ \(0\)\
\-\ septa\\:\\ 0\\.07463396012797881\ \(0\)\
\-\ the\\:\\ 0\\.0741792398676679\ \(0\)\
\-\ favor\\:\\ 0\\.07407682219367143\ \(0\)\
\-\ transmission\\:\\ 0\\.07165307970027862\ \(0\)\
\-\ cm\\:\\ 0\\.07116832521502663\ \(0\)\
\-\ reticular\\:\\ 0\\.07081714361949659\ \(0\)\
\-\ favorable\\:\\ 0\\.07081714361949659\ \(0\)\
\-\ are\\:\\ 0\\.07053267273650896\ \(0\)\
\-\ cystadenocarcinoma\\:\\ 0\\.06931658111665705\ \(0\)\
\-\ intrauterine\\:\\ 0\\.06897173283956477\ \(0\)\
\-\ functioning\\:\\ 0\\.06863749697989716\ \(0\)\
\-\ likelihood\\:\\ 0\\.06831323981488642\ \(0\)\
\-\ is\\:\\ 0\\.06787234691386387\ \(0\)\
\-\ septations\\:\\ 0\\.06710512828047935\ \(0\)\
\-\ follow\\:\\ 0\\.0668033249564858\ \(0\)\
\-\ epithelial\\:\\ 0\\.06654799034617197\ \(0\)\
\-\ documented\\:\\ 0\\.06627978392005887\ \(0\)\
\-\ original\\:\\ 0\\.06576245717889707\ \(0\)\
\-\ resolve\\:\\ 0\\.06551274943742005\ \(0\)\
\-\ or\\:\\ 0\\.06466403640653284\ \(0\)\
\-\ ensure\\:\\ 0\\.0645676485345424\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0642389459509317\ \(0\)\
\-\ cystadenoma\\:\\ 0\\.06270104397545699\ \(0\)\
\-\ strongly\\:\\ 0\\.0623264617395553\ \(0\)\
\-\ greatest\\:\\ 0\\.061964367930864454\ \(0\)\
\-\ adnexal\\:\\ 0\\.06178774926915759\ \(0\)\
\-\ torsion\\:\\ 0\\.06178774926915759\ \(0\)\
\-\ up\\:\\ 0\\.06129826469408747\ \(0\)\
\-\ findings\\:\\ 0\\.061159201286249146\ \(0\)\
\-\ functional\\:\\ 0\\.06078440796738697\ \(0\)\
\-\ inner\\:\\ 0\\.060625838605641254\ \(0\)\
\-\ echogenicity\\:\\ 0\\.060469550896749234\ \(0\)\
\-\ variable\\:\\ 0\\.06016356422952004\ \(0\)\
\-\ ddx\\:\\ 0\\.05888422746697476\ \(0\)\
\-\ complicated\\:\\ 0\\.058750952072559405\ \(0\)\
\-\ germ\\:\\ 0\\.05786118398608531\ \(0\)\
\-\ neoplasms\\:\\ 0\\.05773982173612724\ \(0\)\
\-\ thickness\\:\\ 0\\.05750109106316416\ \(0\)\
\-\ order\\:\\ 0\\.057267494783286556\ \(0\)\
\-\ different\\:\\ 0\\.05670458082737532\ \(0\)\
\-\ which\\:\\ 0\\.05634739052528219\ \(0\)\
\-\ color\\:\\ 0\\.055860520730978906\ \(0\)\
\-\ sonographic\\:\\ 0\\.055759479924497674\ \(0\)\
\-\ doppler\\:\\ 0\\.055461877517329755\ \(0\)\
\-\ ectopic\\:\\ 0\\.05479762989205584\ \(0\)\
\-\ followup\\:\\ 0\\.054705968517964235\ \(0\)\
\-\ period\\:\\ 0\\.054171673511886904\ \(0\)\
\-\ included\\:\\ 0\\.05357983328489823\ \(0\)\
\-\ decrease\\:\\ 0\\.0532555761198875\ \(0\)\
\-\ phase\\:\\ 0\\.053018581808269356\ \(0\)\
\-\ structure\\:\\ 0\\.052940719049249775\ \(0\)\
\-\ appendicitis\\:\\ 0\\.05255956385800676\ \(0\)\
\-\ dermoid\\:\\ 0\\.05233712997485266\ \(0\)\
\-\ indicated\\:\\ 0\\.0509603772376202\ \(0\)\
\-\ admitted\\:\\ 0\\.05076812782293516\ \(0\)\
\-\ good\\:\\ 0\\.05039354558703347\ \(0\)\
\-\ be\\:\\ 0\\.0502691522663715\ \(0\)\
\-\ best\\:\\ 0\\.04985483311663576\ \(0\)\
\-\ features\\:\\ 0\\.04985483311663576\ \(0\)\
\-\ diameter\\:\\ 0\\.049796592717742796\ \(0\)\
\-\ as\\:\\ 0\\.04978282658551486\ \(0\)\
\-\ outside\\:\\ 0\\.049738662935787104\ \(0\)\
\-\ absence\\:\\ 0\\.04939742623258349\ \(0\)\
\-\ of\\:\\ 0\\.04850096168654986\ \(0\)\
\-\ includes\\:\\ 0\\.04818047797223539\ \(0\)\
\-\ measuring\\:\\ 0\\.0479330456698303\ \(0\)\
\-\ persistent\\:\\ 0\\.04773907965168532\ \(0\)\
\-\ worsening\\:\\ 0\\.04731492044239429\ \(0\)\
\-\ at\\:\\ 0\\.04680593147902546\ \(0\)\
\-\ to\\:\\ 0\\.04646941515991719\ \(0\)\
\-\ malignancy\\:\\ 0\\.046385237297066395\ \(0\)\
\-\ hospital\\:\\ 0\\.045766750978279806\ \(0\)\
\-\ presentation\\:\\ 0\\.04265202817889556\ \(0\)\
\-\ this\\:\\ 0\\.0425809422859692\ \(0\)\
\-\ benign\\:\\ 0\\.04256213683794891\ \(0\)\
\-\ flow\\:\\ 0\\.04126954588416769\ \(0\)\
\-\ finding\\:\\ 0\\.04072698845019737\ \(0\)\
\-\ often\\:\\ 0\\.0404287049451537\ \(0\)\
\-\ should\\:\\ 0\\.0404287049451537\ \(0\)\
\-\ no\\:\\ 0\\.04029718341570061\ \(0\)\
\-\ differential\\:\\ 0\\.04025841554773551\ \(0\)\
\-\ such\\:\\ 0\\.03985564150088109\ \(0\)\
\-\ level\\:\\ 0\\.03742724826523352\ \(0\)\
\-\ on\\:\\ 0\\.03742579009676148\ \(0\)\
\-\ following\\:\\ 0\\.03716993451097104\ \(0\)\
\-\ weeks\\:\\ 0\\.03713366800525842\ \(0\)\
\-\ all\\:\\ 0\\.036883137430678475\ \(0\)\
\-\ through\\:\\ 0\\.036883137430678475\ \(0\)\
\-\ secondary\\:\\ 0\\.036725080841663656\ \(0\)\
\-\ time\\:\\ 0\\.036725080841663656\ \(0\)\
\-\ performed\\:\\ 0\\.036655565030813894\ \(0\)\
\-\ with\\:\\ 0\\.036397455749700325\ \(0\)\
\-\ if\\:\\ 0\\.03600012951730847\ \(0\)\
\-\ lesions\\:\\ 0\\.03558416260751331\ \(0\)\
\-\ low\\:\\ 0\\.035552815375452435\ \(0\)\
\-\ cell\\:\\ 0\\.035443807064691475\ \(0\)\
\-\ signal\\:\\ 0\\.0351231963313961\ \(0\)\
\-\ both\\:\\ 0\\.03455177593826543\ \(0\)\
\-\ can\\:\\ 0\\.03251449135732094\ \(0\)\
\-\ tumor\\:\\ 0\\.03240852165463948\ \(0\)\
\-\ most\\:\\ 0\\.03224570777409035\ \(0\)\
\-\ large\\:\\ 0\\.031044888899300425\ \(0\)\
\-\ but\\:\\ 0\\.03063917195352588\ \(0\)\
\-\ lesion\\:\\ 0\\.029704861889395286\ \(0\)\
\-\ from\\:\\ 0\\.024607768818826977\ \(0\)\
\-\ not\\:\\ 0\\.02446021847378282\ \(0\)\
\-\ mass\\:\\ 0\\.02366695406202404\ \(0\)\
\-\ pain\\:\\ 0\\.022171463378650048\ \(0\)\
\-\ right\\:\\ 0\\.020542206519546947\ \(0\)\
\-\ patient\\:\\ 0\\.020152382253472465\ \(0\)\
